chr9:133738349:G>A Detail (hg19) (ABL1)
Information
Genome
Assembly | Position |
---|---|
hg19 | chr9:133,738,349-133,738,349 |
hg38 | chr9:130,862,962-130,862,962 View the variant detail on this assembly version. |
HGVS
Type | Transcript | Protein |
---|---|---|
RefSeq | NM_005157.5:c.749G>A | NP_005148.2:p.Gly250Glu |
NM_007313.2:c.806G>A | NP_009297.2:p.Gly269Glu | |
Ensemble | ENST00000318560.6:c.749G>A | ENST00000318560.6:p.Gly250Glu |
Summary
MGeND
Clinical significance | |
Variant entry | |
GWAS entry | |
Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
ClinVar
Clinical Significance |
![]() |
Review star | ![]() |
Show details |
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
Clinical significance | Last evaluated | Review status | Condition | Origin | Links |
---|---|---|---|---|---|
![]() |
2015-07-14 | no assertion criteria provided | chronic myelogenous leukemia, BCR-ABL1 positive |
![]() |
Detail |
CIViC
Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
---|---|---|---|---|---|---|---|---|---|
chronic myeloid leukemia | Imatinib | D |
![]() |
![]() |
Resistance | Somatic | 3 | 19075254 | Detail |
chronic myeloid leukemia | Imatinib | C |
![]() |
![]() |
Resistance | Somatic | 15930265 | Detail | |
chronic myeloid leukemia | Nilotinib | D |
![]() |
![]() |
Resistance | Somatic | 2 | 19075254 | Detail |
chronic myeloid leukemia | Bosutinib | C |
![]() |
![]() |
Resistance | Somatic | 2 | 21865346 | Detail |
chronic myeloid leukemia | Bosutinib | C |
![]() |
![]() |
Reduced Sensitivity | Somatic | 2 | 22371878 | Detail |
chronic myeloid leukemia | Dasatinib | B |
![]() |
![]() |
Resistance | Somatic | 3 | 19779040 | Detail |
chronic myeloid leukemia | Dasatinib | C |
![]() |
![]() |
Reduced Sensitivity | Somatic | 1 | 17264298 | Detail |
chronic myeloid leukemia | Axitinib | D |
![]() |
![]() |
Resistance | Somatic | 2 | 25686603 | Detail |
chronic myeloid leukemia | Imatinib Mesylate | D |
![]() |
![]() |
Resistance | Somatic | 2 | 16772610 | Detail |
chronic myeloid leukemia | Nilotinib | D |
![]() |
![]() |
Resistance | Somatic | 2 | 16772610 | Detail |
chronic myeloid leukemia | Imatinib | C |
![]() |
![]() |
Resistance | Somatic | 3 | 22371878 | Detail |
chronic myeloid leukemia | Imatinib Mesylate | B |
![]() |
![]() |
Resistance | Somatic | 1 | 17264298 | Detail |
DisGeNET
[No Data.]
Annotation
Annotations
Descrption | Source | Links |
---|---|---|
A panel of 18 mutations representing 85% of known mutations seen in imatinib CML patents were used t... | CIViC Evidence | Detail |
In two cell-based studies, a panel of either 18 or 16 mutations representing 85% of known mutations ... | CIViC Evidence | Detail |
In an in vitro study, a Ba/F3 cell line stably expressing the G250E mutation in the ABL1 portion of ... | CIViC Evidence | Detail |
In this retrospective study, imatinib-resistant or -intolerant patients, with chronic phase CML and ... | CIViC Evidence | Detail |
This was a retrospective study of dasatinib and/or nilotinib-resistant or -intolerant patients pretr... | CIViC Evidence | Detail |
This is a retrospective study of imatinib-resistant (n = 805) or -intolerant (n = 238), chronic myel... | CIViC Evidence | Detail |
In this phase II multinational study, patients with accelerated phase CML and BCR-ABL fusions were t... | CIViC Evidence | Detail |
In a proliferation assay measuring tritiated thymidine incorporation in the presence of axitinib, Ba... | CIViC Evidence | Detail |
In an in vitro study, stochastic mutations were introduced into the ABL1 region of a stably expresse... | CIViC Evidence | Detail |
In an in vitro study, stochastic mutations were introduced into the ABL1 region of a stably expresse... | CIViC Evidence | Detail |
In a study of 39 chronic phase CML patients with BCR-ABL variants, G250E was seen in 6 imatinib-resi... | CIViC Evidence | Detail |
In a phase II study of 60 imatinib-resistant patients with BCR-ABL mutations, 9 had G250E mutations | CIViC Evidence | Detail |
NM_005157.6(ABL1):c.749G>A (p.Gly250Glu) AND Chronic myelogenous leukemia, BCR-ABL1 positive | ClinVar | Detail |
Overlapped Transcript Coordinates
Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
---|
Overlapped Transcript
Gene | Transcript ID | Chromosome | Start | Stop | Links |
---|
- Gene
- -
- dbSNP
- rs121913453 dbSNP
- Genome
- hg19
- Position
- chr9:133,738,349-133,738,349
- Variant Type
- snv
- Reference Allele
- G
- Alternative Allele
- A
- Variant (CIViC) (CIViC Variant)
- BCR-ABL G250E
- Transcript 1 (CIViC Variant)
- ENST00000318560.5
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/1023
Genome browser